권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 대표형(전거형, Authority) | 생물정보 | 이형(異形, Variant) | 소속 | 직위 | 직업 | 활동분야 | 주기 | 서지 | |
|---|---|---|---|---|---|---|---|---|---|
| 연구/단체명을 입력해주세요. | |||||||||
|
|
|
|
|
|
* 주제를 선택하시면 검색 상세로 이동합니다.
본 연구는 기존의 항정신병 약물에서 팔리페리돈 서방정으로 교체한 조현병 환자를 8주간 전향적으로 관찰하여 환자의 만족도의 변화 및 임상척도와의 연관성을 조사한 개방형 다기관 공동연구이다. 총 374명의 환자를 모집하였으며 이 중 탈락을 제외한 본 연구의 조사대상은 320명을 조사한 결과, 팔리페리돈 서방정으로 교체 후 환자의 만족도는 상승하였으며, 임상적 변화와 환자의 만족도 간의 상관성을 알 수 있었다. 추후 환자의 치료평가에 환자의 만족도를 이용한 다양하고 체계화된 연구들을 통해 조현병의 치료에서 환자 만족도의 유용성을 입증할 수 있을 것이다.
Objective The aim of this study was to demonstrate changes of subjective medication satisfaction and clinical benefit after once-daily paliperidone extended release (ER) in treatment of schizophrenia.
Methods In an open-label, observational, and multicenter study, 374 patients with schizophrenia who switched to paliperidone ER due to any reason were recruited. Medication Satisfaction Questionnaire (MSQ), Clinical Global Impression-Severity (CGI-S), Clinical Global Impression-Improvement and visual analogue scale for sleep (VAS) were assessed at baseline, 4 weeks and 8 weeks after treatment. We also examined the type, frequency, and severity of adverse events newly formed.
Results Among 374 patients, 320 patients (76.5%) were included in the intent-to-treat analysis set. The mean dose of paliperidone ER was 5.33±2.31 mg/day at the initiation. At the endpoint, the mean dose of paliperidone ER was 6.68±3.13 mg/day. The percentages of patients satisfied with medication were changed from 40.9% at baseline to 67.8% at endpoint (p<0.001). Both CGI-S scores and VAS for daytime drowsiness were significantly decreased after 8 weeks (both p<0.0001) and mean scores of MSQ and VAS for sleep quality were improved after 8 weeks (both p<0.0001).
Conclusion After switching to paliperidone ER, 67.8% of patients with schizophrenia who had any reason to switch medication showed subjective satisfaction for medication and clinical improvement without significant adverse events. Regarding that medication satisfaction was associated with changes of clinical states, medication satisfaction can be used for measures for clinical scales in the treatment of schizophrenia.| 기사명 | 저자명 | 페이지 | 원문 | 목차 |
|---|---|---|---|---|
| 중독성 약물에 대한 보상 기억에서 PKMzeta의 역할 | 송민지, 김정훈 | pp.83-87 |
|
|
| 조현병 환자에서 Paliperidone Extended Release의 약물만족도와 치료반응을 조사하기 위한 개방형 다기관 전향적 관찰연구 | 이봉주, 신동환, 서만길, 이요한, 양동석, 박진우, 이주연, 박원명, 전태연, 이상규 [외] | pp.88-96 |
|
|
| 약물 교체가 필요한 조현병 환자에서 Paliperidone Extended Release로의 교체 후 유효성과 안전성에 관한 분석 | 문영선, 나경세, 김철응, 김용식, 윤진상, 안용민, 정희연, 유범희, 전양환, 이상규 [외] | pp.97-106 |
|
|
| 활동 기록기를 이용한 주의력결핍 과잉행동장애 남아의 수면양상 | 김나영, 정종현, 임현국, 서호준, 홍승철 | pp.107-114 |
|
|
| 생체간이식 제공자의 이식 전 심리학적 특성과 이식 후 주관적 통증, 아편유사진통제 사용량 그리고 사용기간의 관계 | 유승민, 신경민, 왕희정, 김봉완, 노재성 | pp.115-121 |
|
|
| Amisulpride에 의해 지연성 안검경련이 발생한 조현병 1예 | 박우리, 공성회, 유제춘, 이창화, 최경숙 | pp.122-125 |
|
| 번호 | 참고문헌 | 국회도서관 소장유무 |
|---|---|---|
| 1 | Johannessen JO. Review: lifetime prevalence of schizophrenia and related disorders is about 5.5 per 1000, but there is significant variation between regions. Evid Based Ment Health 2003;6:74. | 미소장 |
| 2 | Comparing patterns and costs of schizophrenia care in five European countries: the EPSILON study ![]() |
미소장 |
| 3 | Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. ![]() |
미소장 |
| 4 | Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). ![]() |
미소장 |
| 5 | Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial. ![]() |
미소장 |
| 6 | Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study. ![]() |
미소장 |
| 7 | Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study. ![]() |
미소장 |
| 8 | Safety and Tolerability of Oral Paliperidone Extended-Release Tablets in Elderly Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study With Six-Month Open-Label Extension ![]() |
미소장 |
| 9 | A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. ![]() |
미소장 |
| 10 | Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. ![]() |
미소장 |
| 11 | Subjective response to neuroleptics: The effect of a questionnaire about neuroleptic side effects ![]() |
미소장 |
| 12 | Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. ![]() |
미소장 |
| 13 | Kelstrup A, Lund K, Lauritsen B, Bech P. Satisfaction with care reported by psychiatric inpatients. Relationship to diagnosis and medical treatment. Acta Psychiatr Scand 1993;87:374-379. | 미소장 |
| 14 | Patient satisfaction and administrative measures as indicators of the quality of mental health care. ![]() |
미소장 |
| 15 | Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. ![]() |
미소장 |
| 16 | Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial. ![]() |
미소장 |
| 17 | Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone. ![]() |
미소장 |
| 18 | Patient satisfaction with, and acceptability of, atypical antipsychotics. ![]() |
미소장 |
| 19 | Kalali A. Evaluating patient satisfaction: a practical approach. Clear Perspectives 1999;2:18-21. | 미소장 |
| 20 | Fleiss JL, Levin BA, Paik MC. Statistical Methods for Rates and Proportions. 3rd ed. New York: John Wiley & Sons;2003. | 미소장 |
| 21 | Two‐sided confidence intervals for the single proportion: comparison of seven methods ![]() |
미소장 |
| 22 | An overview of patient satisfaction with psychiatric treatment. ![]() |
미소장 |
| 23 | The Relationship of Patient Satisfaction with Care and Clinical Outcomes ![]() |
미소장 |
| 24 | Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. ![]() |
미소장 |
| 25 | Drug therapy in schizophrenia--variability of outcome and prediction of response. ![]() |
미소장 |
| 26 | Evaluation ![]() |
미소장 |
| 27 | A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. ![]() |
미소장 |
| 28 | Metabolism 2007 Outside Reviewers ![]() |
미소장 |
| 29 | The Feasibility Test of Korean Medication Algorithm for the Treatment with Schizophrenic Patients(II): The Problem for Applying Algorithm to the Real Clinical Situation and Opinion of Revision | 소장 |
*표시는 필수 입력사항입니다.
| 전화번호 |
|---|
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내: / 서가번호:
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.